Skip to main content
. Author manuscript; available in PMC: 2024 Nov 15.
Published in final edited form as: Clin Cancer Res. 2024 May 15;30(10):2260–2271. doi: 10.1158/1078-0432.CCR-24-0148

Figure 4.

Figure 4.

STLMS genomic risk stratification for disease-specific survival (DSS)

A 3-tier genomic risk stratification scheme is proposed for DSS. DSS for 195 STLMS patients from the MSK (A) and OS for 317 STLMS patients from AACR GENIE cohorts (B) in low-, intermediate-, and high-risk genomic groups is represented by Kaplan-Meier curves for 195 STLMS cases (global log-rank P and Benjamin-Hochberg adjusted P-values by pairwise analysis).